Education
About Us
Working with TipRanks
Follow Us
Neumora Therapeutics, Inc. (NMRA)
NASDAQ:NMRA
| Dec 24 | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 |
| Gross Profit | $ 0.00 | $ -668.00K | $ 0.00 | $ 0.00 | $ 0.00 |
| Operating Income | $ -263.46M | $ -188.19M | $ -135.87M | $ -237.32M | $ -95.52M |
| EBITDA | $ -262.83M | $ -187.53M | $ -135.28M | $ -236.78M | $ -95.41M |
| Net Income | $ -243.79M | $ -235.93M | $ -130.90M | $ -237.31M | $ -99.27M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 307.58M | $ 453.98M | $ 371.88M | $ 409.25M | $ 191.98M |
| Total Assets | $ 316.97M | $ 496.19M | $ 426.23M | $ 429.30M | $ 197.95M |
| Total Debt | $ 1.85M | $ 5.23M | $ 8.44M | $ 2.05M | $ 2.04M |
| Net Debt | $ -140.29M | $ -368.81M | $ -232.50M | $ -407.19M | $ -189.93M |
| Total Liabilities | $ 29.91M | $ 27.12M | $ 873.08M | $ 754.52M | $ 292.33M |
| Stockholders' Equity | $ 287.06M | $ 469.08M | $ -446.85M | $ -325.22M | $ -94.38M |
| Cash Flow | |||||
| Free Cash Flow | $ -182.94M | $ -163.40M | $ -115.41M | $ -76.24M | $ -28.06M |
| Operating Cash Flow | $ -182.94M | $ -163.28M | $ -114.90M | $ -75.42M | $ -26.76M |
| Investing Cash Flow | $ -70.56M | $ 64.39M | $ -168.01M | $ -817.00K | $ -11.24M |
| Financing Cash Flow | $ 21.60M | $ 231.94M | $ 115.74M | $ 293.51M | $ 230.10M |